首页> 外国专利> PHARMACEUTICAL COMPOSITION COMPRISING I.A. VITAMIN C, MAGNESIUM, GREEN TEA EXTRACT FOR RETARDING CARDIOVASCULAR DISEASES (SMC PROLIFERATION)

PHARMACEUTICAL COMPOSITION COMPRISING I.A. VITAMIN C, MAGNESIUM, GREEN TEA EXTRACT FOR RETARDING CARDIOVASCULAR DISEASES (SMC PROLIFERATION)

机译:包含I.A.的药物成分预防心血管疾病的维生素C,镁,绿茶提取物(SMC增殖)

摘要

The present invention provides pharmaceutical compositions comprising lysine, proline, arginine, vitamin C, magnesium, green tea extract, N-acetyl-cysteine, selenium, copper, manganese and one pharmaceutical acceptable component selected from the group consisting of a carrier, a diluent, and an excipient, wherein the pharmaceutical composition without the acceptable component contains 7-9 wt % magnesium, 20-30 wt % ascorbic acid and 11-25 wt % green tea extract. A method of treating cardiovascular diseases using the pharmaceutical compositions are also disclosed, more preferably for the treatment of post-menopausal women.
机译:本发明提供了药物组合物,其包含赖氨酸,脯氨酸,精氨酸,维生素C,镁,绿茶提取物,N-乙酰基半胱氨酸,硒,铜,锰和一种选自载体的药物可接受的成分,所述载体包括:载体,稀释剂,赋形剂和赋形剂,其中不含可接受组分的药物组合物包含7-9 wt%的镁,20-30 wt%的抗坏血酸和11-25 wt%的绿茶提取物。还公开了一种使用药物组合物治疗心血管疾病的方法,更优选地用于治疗绝经后妇女。

著录项

  • 公开/公告号PL1689381T3

    专利类型

  • 公开/公告日2010-07-30

    原文格式PDF

  • 申请/专利权人 RATH MATTHIAS;

    申请/专利号PL20040764249T

  • 申请日2004-08-18

  • 分类号A61K31/198;A61K31/353;A61K31/375;A61K31/401;A61K31/51;A61K31/525;A61K31/555;A61K33/04;A61K33/06;A61K33/32;A61K33/34;A61K36/82;A61K45/06;A61P9;A61P9/10;

  • 国家 PL

  • 入库时间 2022-08-21 18:45:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号